Jul 2026
Multimodal Nanosheet Artificial Antibodies for Augmented Cancer Immunotherapy
Nanosheet artificial antibodies featuring unique tripeptide assembly phases selectively bound to PD-L1 with nanomolar affinity enabling effective inhibition of the PD-1/PD-L1 signaling pathway are presented, providing an effective therapeutic strategy for cancer treatment.
Yujin Choi, Seongyeon Choi, Hyunjung Shin et al.
· ECS Meeting Abstracts · 0 citations